<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01103882</url>
  </required_header>
  <id_info>
    <org_study_id>INT.CR.LKR1.10</org_study_id>
    <nct_id>NCT01103882</nct_id>
  </id_info>
  <brief_title>Short-Term Clinical Outcome of Total Hip Arthroplasty Using Larger Diameter of 4th Generation Ceramic Bearing</brief_title>
  <official_title>Short-Term Clinical Outcome Including Dislocation Rate and Ceramic Fracture of Total Hip Arthroplasty Using Larger Diameter of 4th Generation Ceramic Bearing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objectives of this clinical study include:&#xD;
&#xD;
        -  Assess the rate of dislocation and fracture of THA using the new (the 4th generation)&#xD;
           ceramic implants.&#xD;
&#xD;
        -  Evaluate the survival rate of THA using the new alumina-zirconia (the 4th generation)&#xD;
           composite ceramic bearing.&#xD;
&#xD;
        -  Investigate the performance of the 4th generation ceramic implants mostly in patients&#xD;
           younger than 50 years.&#xD;
&#xD;
        -  Compare the preoperative and postoperative scores of Harris Hip Score, UCLA Activity&#xD;
           Score and WOMAC.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will evaluate incidence of dislocation and short-term clinical outcome on patients&#xD;
      who undergo large diameter 4th generation ceramic bearing total hip Arthroplasty (&quot;THA&quot;) in&#xD;
      comparison to historical data on 3rd generation CoC THA (28mm) patients. Specifically the&#xD;
      study intends to address the following research topics:&#xD;
&#xD;
        1. The incidence of dislocation after THA with use of the 4th generation Ceramic Bearing in&#xD;
           comparison to 3rd generation Ceramic Bearing.&#xD;
&#xD;
        2. The incidence of ceramic fracture after THA with use of the 4th generation Ceramic&#xD;
           Bearing in comparison to 3rd generation Ceramic Bearing&#xD;
&#xD;
        3. The survival rate, wear rate, and incidence of osteolysis of THA with use of the 4th&#xD;
           generation Ceramic Bearing&#xD;
&#xD;
        4. Range of motion improvement from preoperative to postoperative to support Korean sitting&#xD;
           style after THA with use of the 4th generation Ceramic Bearing.&#xD;
&#xD;
        5. Clinical outcomes, activity level and QoL of patients with use of the 4th generation&#xD;
           Ceramic Bearing.&#xD;
&#xD;
        6. The performance of THA with use of the new ceramic bearing mostly in patients younger&#xD;
           than 50 years.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Dislocation</measure>
    <time_frame>12 month postop</time_frame>
    <description>Number of dislocations</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical Outcomes</measure>
    <time_frame>12 months, 18 months and 30 months</time_frame>
    <description>Harris Hip Score, UCLA and WOMAC</description>
  </secondary_outcome>
  <enrollment type="Actual">277</enrollment>
  <condition>Arthropathy of Hip</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients indicated for total hip arthroplasty&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients suitable for primary Total Hip Replacement&#xD;
&#xD;
          -  Patients with degenerative joint disease (inflammatory or non-inflammatory) or any of&#xD;
             the composite diagnoses of:&#xD;
&#xD;
               1. Osteoarthritis&#xD;
&#xD;
               2. Avascular necrosis&#xD;
&#xD;
               3. Legg Perthes&#xD;
&#xD;
               4. Rheumatoid Arthritis&#xD;
&#xD;
               5. Diastrophic variant&#xD;
&#xD;
               6. Fracture of the pelvis&#xD;
&#xD;
               7. Fused hip&#xD;
&#xD;
               8. Slipped capital epiphysis&#xD;
&#xD;
               9. Subcapital fractures&#xD;
&#xD;
              10. Traumatic arthritis&#xD;
&#xD;
          -  Patients aged over 20&#xD;
&#xD;
          -  Patients must be able to understand instructions and be willing to return for&#xD;
             follow-up&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Absolute contraindications include: infection, sepsis, and osteomyelitis&#xD;
&#xD;
          -  Relative contraindications include:&#xD;
&#xD;
               1. uncooperative patient or patient with neurologic disorders who are incapable of&#xD;
                  following directions,&#xD;
&#xD;
               2. osteoporosis,&#xD;
&#xD;
               3. metabolic disorders which may impair bone formation,&#xD;
&#xD;
               4. osteomalacia,&#xD;
&#xD;
               5. distant foci of infections which may spread to the implant site,&#xD;
&#xD;
               6. rapid joint destruction, marked bone loss or bone resorption apparent on&#xD;
                  roentgenogram, and&#xD;
&#xD;
               7. vascular insufficiency, muscular atrophy, or neuromuscular disease.&#xD;
&#xD;
               8. pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Woon-Hwa Jung, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Murup Hospital, Masan, Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yong-Chan Ha, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chung-Ang University Hosptial, Chung-Ang University College of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yong-Kyun Lee, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tae-Young Kim, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hallym University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hallym University Hospital</name>
      <address>
        <city>Anyang</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Gyeonggi-do</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Murup Hospital</name>
      <address>
        <city>Masan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chung-Ang University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>April 13, 2010</study_first_submitted>
  <study_first_submitted_qc>April 13, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2010</study_first_posted>
  <last_update_submitted>June 21, 2018</last_update_submitted>
  <last_update_submitted_qc>June 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

